Trials / Unknown
UnknownNCT06006104
Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer
A Phase I/II Clinical Study to Evaluate the Pharmacokinetics, Radiation Dosimetry, Safety and Preliminary Efficacy of HRS-4357 in Patients With PSMA Positive Advanced Prostate Cancer
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 49 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of HRS-4357 injection in adult patients with advanced prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-4357 injection | HRS-4357 injection |
Timeline
- Start date
- 2023-09-30
- Primary completion
- 2024-09-30
- Completion
- 2024-10-31
- First posted
- 2023-08-23
- Last updated
- 2023-08-23
Source: ClinicalTrials.gov record NCT06006104. Inclusion in this directory is not an endorsement.